Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 17,22117,240 of 20,252 grants

Completed NON SBIR/STTR CONTRACTS
OPERATION & SUPPORT OF THE CTEP PROTOCOL AND INFORMATION OFFICE (PIO)
NATIONAL CANCER INSTITUTE Unknown United States 2021 – 2024

The Protocol Information Office (PIO), Cancer Therapy Evaluation Program (CTEP), Division of Cancer Treatment and Diagnosis (DCTD), National Cancer Institute (NCI) is responsible f...

$14.86M
USD
Completed NON-SBIR/STTR RPGS
Relationship of bias and negative birth outcomes
NATIONAL CANCER INSTITUTE Duke University United States 2021 – 2026

Perinatal smoking negatively affects the baby and mother as well as healthcare costs; yet, up to one third of women who smoke continue to do so during pregnancy. We tested an SMS t...

$377.1K
USD
Completed NON-SBIR/STTR RPGS
HTS for the discovery of activators of NK cell cytotoxicity
NATIONAL CANCER INSTITUTE Case Western Reserve University United States 2021 – 2025

Abstract Natural killer (NK) cells are lymphocytes that are capable of killing malignant cells without antigen-specific receptor recognition. Due to this property, NK cells have be...

$4.55M
USD
Completed NON-SBIR/STTR RPGS
Treating colon cancer by regulating intestinal immunity through microbial metabolism
NATIONAL CANCER INSTITUTE Columbia University Health Sciences United States 2021 – 2026

PROJECT SUMMARY Colorectal cancer (CRC) is profoundly affected by the intestinal immune system and the intestinal microbiome, which can exert both pro- and anti-cancer effects that...

$5.61M
USD
Completed NON-SBIR/STTR RPGS
Aggressive colorectal cancer subtypes and social disadvantage in a racially diverse cohort
NATIONAL CANCER INSTITUTE University of Michigan At Ann Arbor United States 2021 – 2026

ABSTRACT While overall colorectal cancer (CRC) incidence and mortality have declined over the last several decades, CRC incidence and mortality rates continue to be higher in Afric...

$6.55M
USD
Completed NON-SBIR/STTR RPGS
Direct therapeutic intervention of the tumor microenvironment with a potent inhibitor of fibronectin assembly
NATIONAL CANCER INSTITUTE University of Wisconsin-Madison United States 2021 – 2023

PROJECT SUMMARY Among the hallmarks of cancer, the extracellular matrix contributes to the regulation of each of the hallmark principles underlying tumor progression.Importantly, e...

$1.77M
USD
Completed NON-SBIR/STTR RPGS
Elucidating the role of the SWI/SNF complex in mediating hormone therapy resistance in breast cancer
NATIONAL CANCER INSTITUTE Johns Hopkins University United States 2021 – 2023

PROJECT SUMMARY Approximately 70% of breast cancers express estrogen receptor (ER) and are treated typically with endocrine therapy.Despite the clinical benefit obtained from sever...

$2.5M
USD
Completed NON-SBIR/STTR RPGS
Socio-environmental context in monoclonal gammopathy of undetermined significance (MGUS) disparities
NATIONAL CANCER INSTITUTE Boston University Medical Campus United States 2021 – 2026

ABSTRACT Compared to non-Hispanic whites, African Americans have a more than 2-fold higher incidence of multiple myeloma (MM) and its asymptomatic precursor condition, monoclonal g...

$7.6M
USD
Completed NON-SBIR/STTR RPGS
Impact of e-cigarette characteristics and marketing on tobacco use and health: A longitudinal study among U.S. youth and adults
NATIONAL CANCER INSTITUTE New York University School of Medicine United States 2021 – 2023

PROJECT SUMMARY/ABSTRACT E-cigarette use has increased rapidly, particularly among youth and young adults. The appealing flavors are a primary reason for young people to initiate a...

$2.45M
USD
Completed NON-SBIR/STTR RPGS
The Effects of IQOS Use on Cigarette Smoking Behavior
NATIONAL CANCER INSTITUTE University of Pennsylvania United States 2021 – 2024

PROJECT SUMMARY Despite increased morbidity and mortality, 34 million adults in the United States smoke combustible cigarettes.Heat-not-burn (HNB) tobacco products are an emerging...

$4.61M
USD
Completed OTHER RESEARCH-RELATED
Malawi Cancer Outcomes Research Program (M-CORP)
NATIONAL CANCER INSTITUTE University of North Carolina Chapel Hill United States 2021 – 2026

PROJECT SUMMARY Globally, there are more deaths from cancer than from HIV, tuberculosis, and malaria combined.In 2018, there were more than 18 million new cancer cases and 9.5 mill...

$2.69M
USD
Completed NON-SBIR/STTR RPGS
Impact of sugary drinks on gut microbiota and development of young-onset colorectal cancer
NATIONAL CANCER INSTITUTE Baylor College of Medicine United States 2021 – 2022

Project Summary One of the most disturbing phenomena in colorectal cancer (CRC) in the US in the past four decades is its increasing incidence and mortality in adults younger than...

$2.51M
USD
Completed TRAINING, INDIVIDUAL
Clinical trial data analysis to design novel treatment regimens in oncology
NATIONAL CANCER INSTITUTE Harvard Medical School United States 2021 – 2024

Project summary Despite the recent development of new treatment modalities in oncology, the overall approval rate for cancer therapeutics is low: only 3% of drugs tested in a phase...

$377.5K
USD
Completed TRAINING, INDIVIDUAL
Bacterial Rogue Methyltransferases Inducing Human Epimutations
NATIONAL CANCER INSTITUTE Cleveland Clinic Lerner Com-Cwru United States 2021 – 2023

PROJECT SUMMARY: DNA methylation is dysregulated in every form of cancer.While there is substantial knowledge regarding the location and function of abnormal DNA methylation across...

$704.6K
USD
Completed TRAINING, INDIVIDUAL
Elucidating the role of gut, blood, and tumor microbiota in brain metastasis
NATIONAL CANCER INSTITUTE University of Tx Md Anderson Can Ctr United States 2021 – 2024

Project Summary Brain metastasis is a substantial clinical challenge associated with rising incidence and significant morbidity and mortality.Understanding the mechanisms underlyin...

$659.9K
USD
Completed TRAINING, INDIVIDUAL
Role of IRF2BP2 in Tumor Immune Evasion
NATIONAL CANCER INSTITUTE Case Western Reserve University United States 2021 – 2025

PROJECT ABSTRACT Understanding the tumor microenvironment (TME) and the prognostic relevance of the cells contributing to it is vital for developing novel treatments for medullobla...

$510.4K
USD
Completed NON-SBIR/STTR RPGS
Characterizing and Targeting BAX- and BAK-Dependent Cell Death in Cancer
NATIONAL CANCER INSTITUTE Sloan-Kettering Inst Can Research United States 2021 – 2026

PROJECT SUMMARY The incorporation of Immune checkpoint blockade into anticancer armamentarium has revolutionized cancer therapy in recent years, with FDA approved agents in multipl...

$5.14M
USD
Completed NON-SBIR/STTR RPGS
Understanding the Mechanisms of DC Licensing in CD8 T Cell Priming
NATIONAL CANCER INSTITUTE Washington University United States 2021 – 2026

ABSTRACT Effective responses to viruses, intracellular pathogens and tumors rely on the successful expansion and arming of cytolytic CD8 T cells from a naïve and quiescent T cell r...

$4.78M
USD
Completed OTHER RESEARCH-RELATED
2021 Summer's Way Rhabdomyosarcoma Workshop. Bringing researchers, clinicians, industry scientists, families, and foundations together to collaboratively advace RMS research and therapeutics.
NATIONAL CANCER INSTITUTE Summer'S Way Foundation United States 2021 – 2022

Project Summary Abstract/2021 Summer?s Way Rhabdomyosarcoma Workshop Rhabdomyosarcoma (RMS) is a rare childhood cancer associated with a high mortality rate. Treatment options are...

$50K
USD
Completed NON-SBIR/STTR RPGS
Validation of predictive liquid biomarkers for patients with metastatic prostate cancer
NATIONAL CANCER INSTITUTE University of Wisconsin-Madison United States 2021 – 2023

Project Summary/Abstract The University of Wisconsin Carbone Cancer Center (UWCCC), Duke University and Memorial Sloan Kettering Cancer Center (MSKCC) seek support for establishing...

$1.91M
USD